AC008964.1 | | | | | | | Tissue enhanced |
AC023590.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AIM2 | Absent in melanoma 2 | | | | | | Tissue enhanced |
AIRE | Autoimmune regulator | Disease related genes Transcription factors
| | | | | Tissue enhanced |
ANXA2R | Annexin A2 receptor | | | | | | Tissue enhanced |
AP001350.1 | Uncharacterized protein | | | | | | Tissue enhanced |
BACH2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
BANK1 | B-cell scaffold protein with ankyrin repeats 1 | Disease related genes
| | | | | Tissue enhanced |
BATF | Basic leucine zipper transcription factor, ATF-like | Transcription factors
| | | | | Tissue enhanced |
BFSP2 | Beaded filament structural protein 2, phakinin | Disease related genes
| | | | | Tissue enhanced |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CARD11 | Caspase recruitment domain family, member 11 | Cancer-related genes Disease related genes
| | | | | Tissue enhanced |
CCL19 | Chemokine (C-C motif) ligand 19 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CCL21 | Chemokine (C-C motif) ligand 21 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD180 | CD180 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD22 | CD22 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD247 | CD247 molecule | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD28 | CD28 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD3D | CD3d molecule, delta (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CD3G | CD3g molecule, gamma (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD40LG | CD40 ligand | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CD48 | CD48 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD5 | CD5 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD6 | CD6 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD69 | CD69 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD79A | CD79a molecule, immunoglobulin-associated alpha | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CD80 | CD80 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD84 | CD84 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD8B | CD8b molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD96 | CD96 molecule | CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CETP | Cholesteryl ester transfer protein, plasma | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLEC4C | C-type lectin domain family 4, member C | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC9A | C-type lectin domain family 9, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CLECL1 | C-type lectin-like 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLLU1OS | Chronic lymphocytic leukemia up-regulated 1 opposite strand | | | | | | Tissue enhanced |
CRTAM | Cytotoxic and regulatory T cell molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CTB-133G6.1 | | Predicted membrane proteins
| | | | | Tissue enhanced |
CTD-2207O23.3 | Rho guanine nucleotide exchange factor 18 | | | | | | Tissue enhanced |
CTD-2215E18.1 | Uncharacterized protein | | | | | | Tissue enhanced |
CTLA4 | Cytotoxic T-lymphocyte-associated protein 4 | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCR3 | Chemokine (C-X-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
DTX1 | Deltex homolog 1 (Drosophila) | | | | | | Tissue enhanced |
ELL3 | Elongation factor RNA polymerase II-like 3 | | | | | | Tissue enhanced |
EN1 | Engrailed homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
EOMES | Eomesodermin | Disease related genes Transcription factors
| | | | | Tissue enhanced |
FAIM3 | Fas apoptotic inhibitory molecule 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |